The relationship between physicians and the pharmaceutical industry Essay Example for Free

The relationship between physicians and the pharmaceutical manufacture EssayThere are many issues k nonted with the relationship between physicians and the pharmaceutical industry. According to David Goldbloom, he proposed that gifts that the pharmaceutical industry wanted to give physicians should not be gifts, but instead should be materials that are sold to the physician at cost. This not only(prenominal) would subdue the appearance of impropriety, but would lower the overall cost of the drug to consumers. This position was picked up by the American Medical Students Association, who stated that there should be a complete ban on industry involvement in education. 2) honorable and policy issues in interrogation involving human participants. When a pharmaceutical lodge decides that they are going to conduct a human clinical trial, there are issues of the morality and morality of conducting clinical trials. One of the first things is that the look subject must have full i nformed acquiesce about the topic and the implications of the research that they are going to be involved in. Second, the government has in crop in protecting the clinical research subject to assure that they are treated in an honourable way and are not subject to abuse or maltreatment in the clinical research process.In these regulations, the physical and emotional effects on the subject are minimized, additionally, the psychological and physical effects are reasonable, given the medical subject matter involved. Finally, all research involving human subjects must be analyzed and approved by the FDA in order to assure that the FDAs guidelines are being met and that the research is indeed safe for human subjects. 3) Research involving persons with mental disorders that may affect decision-making capacity.Many of the same honourable considerations that involve research on human participants also apply to research trials on participants with mental disorders that may affect their decision making capacity. The only additional consideration is that there is an advocate for the person that should be in a position to assure that the medical and mental issues of the participant is indeed taken finagle of. pharmaceutic companies should assure that all ethical guidelines and laws are followed to assure that those individuals with mental disorders are not taken advantage of in the clinical research process.4) Bias in pharmaceutical sponsored (funded) clinical trials. There is a natural bias inherent in a pharmaceutical company conducting the clinical research on a drug. First, the pharmaceutical company has invested years and millions of dollars in developing and refining a drug. If that drug is not approved, they are out all that time and money. The individuals that work for the company and that are conducting the testing may smack pressured to manipulate the results to come out a plastered way to assure that the company does not doze off the money and time t hey have invested in the drug development process.5) Relationship between clinical investigators and the pharmaceutical industry. When clinical investigators are investigating the aptitude of a drug, they should avoid the appearance of impropriety by working(a) to maintain their independency. The investigator should not have any relationship with the industry in which they work. This helps them to maintain their independence and they are better able to accomplish their job in an efficient and professional manner. Investigators should also avoid paid consultancies as they give the appearance of a conflict of interest.Investigators are there to investigate the efficacy of the drug in question, and they should be left to do their job without being pressured to achieve a certain result for the pharmaceutical company. 6) Corporate hand in clinical trials and their contracts with academia. The corporate hand in academia should be one that is very light. There should be a full disclosur e of all fiducial obligations that academia has with the corporate world, and it should be up to an independent panel to determine if that financial relationship is bear upon the academic independence of the researcher.Contracts with academia should be ones that do not have any implicit or explicit strings attached, and should not be contingent on a certain performance level. work Cited (1999, March 11). Research Involving Individuals with Questionable Capacity to Consent . Retrieved June 20, 2009, from U. S. Department of Health and Human Services weave site http//grants. nih. gov/grants/policy/questionablecapacity. htm Bero, L. (2003, June 11). Corporate and Economic Pressures on Academic Freedom. RetrievedJune 20, 2009, from University of California Web site http//www. universityofcalifornia. edu/senate/committees/ucaf/afforum/bero. pdf Chopra, S. (2003, July 2). industriousness Funding of clinical Trials Benefit or Bias?. Retrieved June 20, 2009, from www. jama. ama-assn. org Web site http//jama. ama-assn. org/cgi/reprint/290/1/113. pdf Goldbloom, D. S. Physicians and the Pharmaceutical Industry . Retrieved June 20, 2009, from Canadian Psychiatric Association Web site http//ww1. cpa- apc.org8080/publications/archives/bulletin/2003/october/editorialEn. asp Kapp, M. B. (2006). Ethical and legal issues in research involving human subjects do you want a piece of me?. Retrieved June 20, 2009, from Journal of Clinical Pathology Web site http//jcp. bmjjournals. com/cgi/content/full/59/4/335 Panacek, E Guidelines for Clinical Investigator pursuit in Industry-sponsored Clinical Trials. Retrieved June 20, 2009, from www. saem. org Web site http//www. saem. org/download/edward. pdf